Athersys, Inc. (ATHXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Dec 26, 2024, 4:00 PM EST
Athersys Revenue
Athersys had revenue of $80.00K in the twelve months ending September 30, 2023, down -98.67% year-over-year. In the year 2022, Athersys had annual revenue of $5.33M, down -3.43%.
Revenue (ttm)
80.00K
Revenue Growth
-98.67%
P/S Ratio
0.00
Revenue / Employee
3.33K
Employees
24
Market Cap
62.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 5.33M | -189.00K | -3.43% |
| Dec 31, 2021 | 5.51M | 4.07M | 282.92% |
| Dec 31, 2020 | 1.44M | -4.19M | -74.44% |
| Dec 31, 2019 | 5.63M | -18.66M | -76.81% |
| Dec 31, 2018 | 24.29M | 20.58M | 555.10% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |